Skip to content

NEW YORK STATE DEPARTMENT OF HEALTH AIDS INSTITUTE    See Our Statement on Inclusive Care

  • JOIN OUR MAIL LIST
  • ABOUT US
  • POCKET GUIDES & SLIDES
  • HOME

  • Viremic Podcast
  • Facebook
  • LinkedIn
  • Instagram
  • HIV Testing and Acute HIV
  • HIV Treatment
  • PEP and PrEP
  • Hepatitis Care
  • Primary and Specialty HIV Care
  • HPV-Related Cancer Prevention
  • Sexual Health
  • Perinatal HIV Prevention
  • Substance Use

Updated: Use of Injectable CAB/RPV LA as Replacement ART in Virally Suppressed Adults (7/23/25)

Use of Injectable CAB/RPV LA as Replacement ART in Virally Suppressed Adults (7/23/25)

Post navigation

Previous Previous post: NYRx: Extencilline added as reimbursable drug (7/22/25)
Next Next post: NYSDOH & NYCDOH&MH Encourage HPV Vaccination Starting at Age 9 to Prevent Cancer (7/23/25)

This website is managed by the Clinical Guidelines Program in the JHU School of Medicine, Division of Infectious Diseases, on behalf of the NYSDOH AIDS Institute. Carnegie 3, Rm 386, 600 North Wolfe Street, Baltimore, MD 21287

Quick Links: About | Guideline Development | About the Site | New York State Department of Health | AIDS Institute

Contact us: aiguidelines@jhmi.edu

Copyright © Johns Hopkins University HIV Clinical Guidelines Program 2000-2025. All Rights Reserved.

What can I help you find in the guidelines?